CrossRef Text and Data Mining
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.
Dipeptidyl Peptidase-4 Inhibitors versus Other Antidiabetic Drugs Added to Metformin Monotherapy in Diabetic Retinopathy Progression: A Real World-Based Cohort Study
Yoo-Ri Chung, Kyoung Hwa Ha, Hyeon Chang Kim, Sang Jun Park, Kihwang Lee, Dae Jung Kim
Diabetes Metab J. 2019;43(5):640-648.   Published online February 20, 2019
DOI: https://doi.org/10.4093/dmj.2018.0137

Excel Download

Letter: Dipeptidyl Peptidase-4 Inhibitors versus Other Antidiabetic Drugs Added to Metformin Monotherapy in Diabetic Retinopathy Progression: A Real World-Based Cohort Study (Diabetes Metab J 2019;43:640–8)
Jun Sung Moon
Diabetes & Metabolism Journal. 2019;43(6):911   Crossref logo
Link1 Link2 Link3
Response: Dipeptidyl Peptidase-4 Inhibitors versus Other Antidiabetic Drugs Added to Metformin Monotherapy in Diabetic Retinopathy Progression: A Real World-Based Cohort Study (Diabetes Metab J 2019;43:640–8)
Yoo-Ri Chung, Kyoung Hwa Ha, Kihwang Lee, Dae Jung Kim
Diabetes & Metabolism Journal. 2019;43(6):917   Crossref logo
Link1 Link2 Link3
Dipeptidyl Peptidase-4 Inhibitors versus Other Antidiabetic Drugs Added to Metformin Monotherapy in Diabetic Retinopathy Progression: A Real World-Based Cohort Study
Yoo-Ri Chung, Kyoung Hwa Ha, Hyeon Chang Kim, Sang Jun Park, Kihwang Lee, Dae Jung Kim
Diabetes & Metabolism Journal. 2019;43(5):640   Crossref logo
Link1 Link2 Link3
Dipeptidyl peptidase‐4 inhibitors and risk of diabetic retinopathy progression in patients with type 2 diabetes: a population‐based cohort study
Acta Ophthalmologica. 2018;96(S261):23-23   Crossref logo
Link1 Link2 Link3
Effects of sodium-glucose cotransporter-2 inhibitors and dipeptidyl peptidase-4 inhibitors on diabetic retinopathy and its progression: A real-world Korean study
Yoo-Ri Chung, Kyoung Hwa Ha, Kihwang Lee, Dae Jung Kim
PLOS ONE. 2019;14(10):e0224549   Crossref logo
Link1
Association Between Dipeptidyl Peptidase-4 Inhibitors and Diabetic Retinopathy in Korean Patients With Type 2 Diabetes Mellitus: Nationwide Population-Based Cohort Study
Gyu Chul Oh, You-Jeong Ki, Kyung Woo Park, Kyung-Do Han, Hyo-Soo Kim
. 2021;   Crossref logo
Link1 Link2
FC 125: Comparative Effectiveness of Dipeptidyl Peptidase-4 Inhibitors versus Sulfonylureas in Addition to Metformin: A Population-Based Cohort Study of Patients With Diabetes
Hon-Yen Wu, Jui Wang, Kuo-Liong Chien
Nephrology Dialysis Transplantation. 2022;37(Supplement_3):   Crossref logo
Link1 Link2
Cardiovascular risks associated with dipeptidyl peptidase‐4 inhibitors monotherapy compared with other antidiabetes drugs in the Japanese population: A nationwide cohort study
Maki Komamine, Kazuhiro Kajiyama, Chieko Ishiguro, Yoshiaki Uyama
Pharmacoepidemiology and Drug Safety. 2019;28(9):1166-1174   Crossref logo
Link1 Link2 Link3
Metformin combined with dipeptidyl peptidase-4 inhibitors or metformin combined with sulfonylureas in patients with type 2 diabetes: A real world analysis of the South Korean national cohort
Yeon Young Cho, Sung-Il Cho
Metabolism. 2018;85:14-22   Crossref logo
Link1 Link2
Cardioprotective effects of dipeptidyl peptidase-4 inhibitors versus sulfonylureas in addition to metformin: A nationwide cohort study of patients with type 2 diabetes
Jui Wang, Hon-Yen Wu, Kuo-Liong Chien
Diabetes & Metabolism. 2022;48(3):101299   Crossref logo
Link1 Link2